HK1215391A1 - 使用胎盘细胞外基质治疗口腔病变 - Google Patents

使用胎盘细胞外基质治疗口腔病变 Download PDF

Info

Publication number
HK1215391A1
HK1215391A1 HK16103392.0A HK16103392A HK1215391A1 HK 1215391 A1 HK1215391 A1 HK 1215391A1 HK 16103392 A HK16103392 A HK 16103392A HK 1215391 A1 HK1215391 A1 HK 1215391A1
Authority
HK
Hong Kong
Prior art keywords
extracellular matrix
oral lesions
treating oral
placental extracellular
placental
Prior art date
Application number
HK16103392.0A
Other languages
English (en)
Chinese (zh)
Inventor
羅伯特．
罗伯特．J．哈黎里
．哈黎裡
乔迪．P．格尼
喬迪．
莫希特．B．巴迪亚
．格尼
沃尔夫冈．霍弗伽纳尔
莫希特．
．巴迪亞
沃爾夫岡．霍弗伽納爾
Original Assignee
人类起源公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 人类起源公司 filed Critical 人类起源公司
Publication of HK1215391A1 publication Critical patent/HK1215391A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK16103392.0A 2012-12-07 2013-12-06 使用胎盘细胞外基质治疗口腔病变 HK1215391A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261734665P 2012-12-07 2012-12-07
US61/734,665 2012-12-07
PCT/US2013/073593 WO2014089440A1 (en) 2012-12-07 2013-12-06 Treating oral lesions using placental extracellular matrix

Publications (1)

Publication Number Publication Date
HK1215391A1 true HK1215391A1 (zh) 2016-08-26

Family

ID=50884026

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103392.0A HK1215391A1 (zh) 2012-12-07 2013-12-06 使用胎盘细胞外基质治疗口腔病变

Country Status (9)

Country Link
US (1) US20150313948A1 (https=)
EP (2) EP3838280A1 (https=)
JP (4) JP2016501245A (https=)
CN (2) CN104955465A (https=)
BR (1) BR112015013125A2 (https=)
CA (1) CA2894160C (https=)
HK (1) HK1215391A1 (https=)
RU (2) RU2019101641A (https=)
WO (1) WO2014089440A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2897625B1 (en) 2012-09-10 2019-10-23 Wake Forest University Health Sciences Amniotic membrane and its use in wound healing and tissue engineering constructs
SG10201901713RA (en) * 2014-08-25 2019-03-28 Hli Cellular Therapeutics Llc Extracellular matrix compositions
EP3200809B1 (en) * 2014-10-02 2023-09-13 Wake Forest University Health Sciences, Inc. Amniotic membrane powder and its use in wound healing and tissue engineering constructs
CN110095421B (zh) * 2019-05-17 2022-02-08 淮海工学院 一种胶原蛋白变性温度的测定方法
CN110975010B (zh) * 2019-11-25 2022-02-15 银丰低温医学科技有限公司 一种胎盘组织基质材料及其制备方法
CN111494223A (zh) * 2020-04-22 2020-08-07 福建汉氏联合干细胞科技有限公司 一种胎盘源干细胞漱口修复液
WO2025147712A1 (en) * 2024-01-05 2025-07-10 Viscus Biologics, Llc Xenogeneic oral repair compositions and implants thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185011A (en) 1978-10-16 1980-01-22 Firma Carl Freudenberg Process for the production of collagen fibers
DE3042860A1 (de) 1980-11-13 1982-06-09 Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin
FR2516927B1 (fr) 1981-11-26 1986-05-23 Merieux Fond Procede de preparation industrielle de materiaux collageniques a partir de tissus placentaires humains, materiaux collageniques humains obtenus, leur application comme biomateriaux
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4642117A (en) 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US5436135A (en) 1985-09-02 1995-07-25 Pasteur Merieux Serums Et Vaccins New preparation of placenta collagen, their extraction method and their applications
US4852640A (en) 1986-03-28 1989-08-01 Exothermics-Eclipse Inc. Recuperative heat exchanger
US5660692A (en) 1988-02-24 1997-08-26 Cedars-Sinai Medical Center Method of crosslinking amino acid-containing polymers using photoactivatable chemical crosslinkers
US5008116A (en) 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
FR2692582B1 (fr) 1992-06-18 1998-09-18 Flamel Tech Sa Nouveaux derives reticulables de collagene, leur procede d'obtention et leur application a la preparation de biomateriaux.
US5428022A (en) 1992-07-29 1995-06-27 Collagen Corporation Composition of low type III content human placental collagen
FR2699184B1 (fr) 1992-12-16 1995-03-10 Flamel Tech Sa Nouveaux dérivés de collagène, leur procédé d'obtention et leur application à la préparation de biomatériaux.
CA2247199A1 (en) 1996-03-04 1997-09-12 Edwards Lifesciences Corporation Nonpolymeric epoxy compounds for cross-linking biological tissue and bioprosthetic grafts prepared thereby
US5814328A (en) 1997-01-13 1998-09-29 Gunasekaran; Subramanian Preparation of collagen using papain and a reducing agent
US6117979A (en) 1997-08-18 2000-09-12 Medtronic, Inc. Process for making a bioprosthetic device and implants produced therefrom
EP2305795B1 (en) 2000-12-06 2019-07-03 Celularity, Inc. Method of collecting placental stem cells
EP2316918B1 (en) 2001-02-14 2015-07-01 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
JP2003119157A (ja) * 2001-08-06 2003-04-23 Kikuji Yamashita コラーゲンを含有する洗口剤
US9084772B2 (en) 2001-08-31 2015-07-21 Orthopeutics L.P. Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
US20030124178A1 (en) * 2001-12-28 2003-07-03 Haley Jeffrey T. Soft, adherent, soluble oral patch
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20060134201A1 (en) * 2004-12-16 2006-06-22 Haley Jeffrey T Collagen troches for treating mouth lesions
US7928280B2 (en) * 2005-07-13 2011-04-19 Anthrogenesis Corporation Treatment of leg ulcers using placenta derived collagen biofabric
PL2471907T3 (pl) 2005-12-29 2019-07-31 Celularity, Inc. Populacje komórek macierzystych łożyska
CN101622007A (zh) * 2006-10-06 2010-01-06 人类起源公司 天然(端肽)胎盘胶原组合物
DE502006006810D1 (de) * 2006-11-06 2010-06-02 Lohmann & Rauscher Gmbh & Co Produkt zur Versorgung von Entzündungen, Druckstellen und/oder Aphten im Oralbereich sowie Verwendung eines solchen Produkts
EP4559488A3 (en) * 2007-09-07 2025-08-13 MiMedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same
US9304134B2 (en) * 2010-11-23 2016-04-05 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of anemia

Also Published As

Publication number Publication date
JP2019108329A (ja) 2019-07-04
BR112015013125A2 (pt) 2017-07-11
JP2016501245A (ja) 2016-01-18
EP2928481A1 (en) 2015-10-14
JP2023065422A (ja) 2023-05-12
RU2019101641A (ru) 2019-03-20
CA2894160C (en) 2024-01-02
EP2928481A4 (en) 2016-09-14
CA2894160A1 (en) 2014-06-12
CN104955465A (zh) 2015-09-30
WO2014089440A1 (en) 2014-06-12
CN117899116A (zh) 2024-04-19
RU2019101641A3 (https=) 2021-12-28
RU2015127077A (ru) 2017-01-12
JP2021073217A (ja) 2021-05-13
US20150313948A1 (en) 2015-11-05
EP3838280A1 (en) 2021-06-23

Similar Documents

Publication Publication Date Title
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
WO2012048099A3 (en) Nanoparticle-loaded cells
WO2012055567A3 (en) Use of malononitrilamides in neuropathic pain
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
WO2012030993A3 (en) Skin compositions and methods of use thereof
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
SG10201408158SA (en) Composition and methods used during anti-hiv treatment
IL235923B (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical preparations thereof
IL237649B (en) Polymer meters drug for use in the prevention, diagnosis and/or treatment of diseases of the joint
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
HK1215391A1 (zh) 使用胎盘细胞外基质治疗口腔病变
PT2848097T (pt) Dispositivo para o tratamento de plasma de superfícies humanas, animais ou de plantas, em particular da pele ou de áreas de membrana mucosa
ZA201208413B (en) Skin treatment composition
HK1210953A1 (en) Methods for treatment of atherosclerosis
WO2012061390A3 (en) Therapeutic compositions and methods
PT2407151T (pt) Composição para o tratamento de lesões da pele e/ou unhas
EP2673288A1 (en) Peptide for use in the treatment of skin conditions
WO2013123249A3 (en) Formulations and methods for treating ear conditions
WO2015084883A3 (en) Compositions and methods for treating osteoarthritis
IL216717A0 (en) USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
WO2011018477A3 (en) Carnosol for hair and skin care
GB2473735B (en) Skin treatment formulation
AU2010904571A0 (en) Skin Treatment Formulation
AU2009904943A0 (en) Skin Treatment Formulation